Denali Therapeutics Inc. (DNLI) PT Raised to $40 at Goldman Sachs

March 25, 2026 4:02 PM

Goldman Sachs analyst Salveen Richter raised the price target on Denali Therapeutics Inc. (NASDAQ: DNLI) to $40.00 (from $35.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found